Most small cell lung cancer (SCLC) patients relapse within 12 months of starting combination chemotherapy plus radio-therapy, due to the development of acquired chemo-and radio-resistance. This phenomenon relates to the induction of tumour differentiation, resulting in apoptosis-resistant, morphologically variant (v-SCLC) cells, which lack the neuroendocrine expression of classic (c-) SCLC cells. In this study spontaneously adherent SCLC sublines were shown by differential gene expression analysis to provide an in vitro model of variant differentiation in SCLC, with down-regulation of neuroendocrine markers and up-regulation of epithelial differentiation markers cyclin D1, endothelin, the cell adhesion molecules CD 44 and integrin subunits a2, b3 and b4. The sensitivity of adherent SCLC sublines to etoposide, cyclophosphamide and gamma radiation was significantly diminished relative to parent suspension cell lines. Western blot analysis using phosphorylationspecific antibodies to Akt and MAP kinase revealed markedly elevated activation in adherent SCLC sublines, paralleled by increased levels of phosphorylated Bad protein and activated NF-kB. Subcultivation of the adherent sublines on uncoated surfaces reversed their adherent phenotype immediately and under these conditions Akt activity reverted to low levels. These results suggest that c-SCLC cells can differentiate spontaneously to v-SCLC and that the associated cellular adhesion may trigger Akt-dependent inhibition of apoptosis in SCLC cells, thus leading to acquired chemoand radio-resistance.
Introduction
Lung cancer persists as the leading cause of cancerrelated deaths in industrialized nations. Approximately one quarter of lung cancer cases are classified as small cell lung cancer (SCLC), which bears the poorest prognosis of the different lung cancer histologies. Patients with SCLC usually present with inoperable disease, since the tumour is commonly centrally located and tends to metastasize early in the course of the disease. Therefore, the combination of polychemotherapy and radio-therapy forms the cornerstone of treatment. While SCLC tumours are primarily chemo-and radio-sensitive, the development of acquired chemo-and radio-resistance over the subsequent 3 to 12 months is a problem that affects most patients (Brambilla et al., 1991) and the overall 5-year survival rate is only 5% (Worden and Kalemkerian, 2000) .
The mechanisms leading to acquired chemo-and radio-resistance in SCLC are not yet fully understood. The development of acquired resistance seems to correlate temporally, however, with the appearance of histologically variant tumour cells within SCLC (Radice et al., 1982; Brambilla et al., 1991) . These variant SCLC cells diverge from the classical phenotype in their morphology, which resembles that of the non small cell lung cancer (NSCLC) group with an epithelial appearance. Variant SCLC also demonstrates loss of expression of neuroendocrine markers, including chromogranin A and gastrin releasing peptide/ bombesin, which are typically expressed in classic SCLC . Clinically, variant SCLC tumours have been reported to be more aggressive in forming metastases (Fushimi et al., 1996) and experimentally SCLC cells, which have been categorized as 'variant' on the grounds of reduced expression of certain neuroendocrine marker(s), likewise show a greater potential for metastasis in SCID-hu-L mice compared to their classic SCLC counterparts (Shtivelman and Namikawa, 1995) .
Although the induction of multi-drug resistance (MDR) has been proposed as the mechanism accounting for acquired chemo-and radio-resistance in SCLC, results from studies are conflicting and are based largely on the investigation of SCLC cell lines which have undergone long-term exposure to chemotherapeutic agents in vitro. Since the cumulative chemotherapeutic dose received in such an experimental system exceeds by far the tissue concentrations to which a tumour in vivo is cyclically exposed during therapy, its relevance is questionable. Although treatment of P-Glycoprotein (P-gp) negative Lu-24 SCLC cells with etoposide and vincristine induced expression of P-gp and the MDR1 gene product (Abe et al., 1996) , such induction was not found in other cell lines (Supino et al., 1993) . Furthermore, clinical studies investigating expression of lung resistance protein (LRP), mdr1 or P-gp in tumour material after chemotherapy demonstrated that expression was rarely induced and did not correlate with the clinical response (Dingemans et al., 1996; Savaraj et al., 1997) .
A recent hypothesis proposes that cell -matrix interactions at the tumour -stroma interface are able to confer resistance to apoptosis (Sethi et al., 1999; Hazlehurst et al., 2000) , a phenomenon referred to as cell adhesion-mediated drug resistance or CAM-DR. This effect is thought to involve the engagement of integrins, since antibodies directed against b1 integrin subunits are able to revert protection from apoptosis. The subsequent activation of tyrosine kinases probably includes the focal adhesion kinase (FAK) family and PI-3 kinase, which has been shown to be constitutively activated in some SCLC cell lines (Moore et al., 1998) . The downstream effector of PI-3 kinase, serine/ threonine kinase Akt (also known as protein kinase B), is the main mediator of survival signalling, protecting the cell from apoptosis, in part via its inhibitory effects on the pro-apoptotic factor Bad (Datta et al., 1997) . Thus, the PI-3 kinase -Akt pathway may be of particular importance in effecting inhibition of apoptosis in CAM-DR. Whether Akt plays a role in variant SCLC and the development of acquired chemo-and radio-resistance has not been investigated to date. NF-kB has been shown to be activated in tumour cells by both chemotherapy and gamma radiation (Das and White, 1997; Basu et al., 1998) and is thus a further candidate mechanism for the induction of acquired chemo-and radio-resistance in SCLC. The TNF-a/NF-kB pathway exerts both pro-and antiapoptotic effects. While TNF-a itself promotes apoptosis, in parallel it also activates NF-kB, which transcriptionally activates anti-apoptotic factors including Bfl-1 (Zong et al., 1999) and the IAP family (Wang et al., 1998) . The balance of these competing arms of the TNF-a/NF-kB pathway determines the outcome of apoptosis or survival within a particular cell. NF-kBdependent up-regulation of Bfl-1 has been shown to protect human lung adenocarcinoma cells from apoptosis induced by TNF-a and several chemotherapeutic agents (Cheng et al., 2000) . Understanding of the NF-kB pathway has been further clarified by the finding that activation of the protein kinase Akt via Ras or activation of PI-3 kinase by TNF-a or PDGF treatment leads to phosphorylation and activation of IkB kinases, which phosphorylate and degrade IkB (Ozes et al., 1999; Romashkova and Makarov, 1999) . This results in the release, from its complex with IkB, of NF-kB and hence its transport to the nucleus where it effects transcriptional activation of target genes, including anti-apoptotic factors. Constitutive activation of the Akt/NF-kB pathway by HER2/neu has been shown to play a role in blocking apoptosis in a subgroup of breast cancer patients with particularly poor prognosis (Zhou et al., 2000; Pianetti et al., 2001) . The possible role of the Akt/NF-kB pathway in therapy-resistant variant SCLC has not been addressed to date.
Therefore, we were interested to investigate the Akt/ NF-kB pathway in the context of acquired chemo-and radio-resistance in SCLC. The aim of this study was to validate spontaneously adherent SCLC cells as a potential in vitro model system for variant differentiation and, using this novel tool, to investigate whether the Akt/Bad and Akt/NF-kB pathways play a role in the development of acquired chemo-and radioresistance in SCLC.
Results

Adherent sublines as variant SCLC model
The classical SCLC cell lines NCI-H69 and NCI-N592, which grow as suspension cultures, were noted to form spontaneous colonies of adherent cells on poly-L-lysine coated culture flasks and could be subcultured under identical cell culture conditions to establish EDTAresistant adherent sublines (H69ad and N592ad). Figure 1 illustrates the morphology of the parent and adherent cell lines, showing the epithelial-type morphology of the adherent sublines, which resemble NSCLC cells in appearance. DNA fingerprint analysis confirmed that parent and adherent sublines were genetically identical, excluding cell culture contamination (data not shown). Since the epithelial-type morphology of the adherent sublines was similar to that of variant differentiation in SCLC, the expression of markers of neuroendocrine (SCLC-specific) versus epithelial (variant) differentiation was investigated by semi-quantitative RT -PCR analysis. The analysis was extended to investigate the differential expression of cellular adhesion molecules and regulators of growth and apoptosis (Table 1) , whose possible altered activity might contribute to the aggressive behaviour of variant SCLC. The differential expression of specific candidate genes is shown in Figure 2 and the results, assessed by differential integrated density of expression, are summarized in Figure 3 and Table 2 . Adherent sublines down-regulated expression of the neuroendocrine markers chromogranin A, L-dopa-decarboxylase, neuron-specific enolase (NSE), bombesin and c-kit relative to the parent cell lines. Expression of these markers was also diminished or absent in the variant (v-) SCLC cell line NCI-H841 (Gazdar and Minna, 1996) and in the two NSCLC cell lines investigated in parallel. Interestingly, expression of lung resistance protein and E cadherin was also down-regulated in the adherent sublines. Conversely, expression of CD44, Axl, cyclin D1, thrombospondin and endothelin, as well as that of genes coding for the adhesion molecules integrin a2, a3 and b4 subunits, was up-regulated in the adherent sublines and the NSCLC cell lines. These results are consistent with the adherent sublines having undergone differentiation with typical variant features, suggesting that these sublines can serve as an in vitro model of variant SCLC.
Increased resistance of adherent sublines to chemotherapy
The sensitivity of the adherent sublines to a selection of chemotherapeutic agents used in the treatment of SCLC patients was compared to that of the parent c-SCLC cell lines, measured by cytotoxicity assays. Figure 4 shows the responses of N592ad and NCI-N592 after 5 days treatment with each of the topoisomerase II inhibitor etoposide, the alkylating agent cyclophosphamide, the cytotoxic antibiotic doxorubicin or the taxane paclitaxel. As can be seen in Figure 4 and Table 3, N592ad was 71.7-fold more resistant than its parent cell line to etoposide, with IC 50 s of 16.5 mg/ml and 0.23 mg/ml respectively. N592ad showed increased resistance to cyclophosphamide relative to NCI-N592, with IC 50 s of 560 mM and 99 mM respectively (5.6-fold increase). There were also modest differences in the responses of N592ad and NCI-N592 to doxorubicin and paclitaxel ( Figure 4 and Table 3 ). Similarly, H69ad demonstrated markedly increased resistance to etoposide (27.5-fold), with IC 50 s of 5.5 mg/ml and 0.2 mg/ml for H69ad and NCI-H69, Figure 1 Epithelial morphology of the adherent sublines H69ad and N592ad, derived as described below from NCI-H69 and NCI-N592 classic SCLC cells, which grow as suspension aggregates. A small proportion of NCI-H69 and NCI-N592 suspension c-SCLC cells were noted to sink to the bottom of poly-L-lysine coated flasks, becoming spontaneously adherent and over the course of several days gaining an epithelial-type morphology, resembling NSCLC cells. Once these adherent cells had proliferated sufficiently in the culture flask alongside their parental suspension cells to be viable on their own in culture, they were subcultured under identical culture conditions to create independent adherent H69ad and N592ad sublines. DNA fingerprint analysis confirmed that parent and adherent sublines were genetically identical respectively. This result was in spite of a shorter doubling time in culture for H69ad (50 h) than NCI-H69 (53 h). The sensitivity of H69ad to cyclophosphamide was modestly reduced by a factor of 2.6 (Table 3) , while sensitivity to doxorubicin and paclitaxel did not differ significantly from that of the parent cell line NCI-H69. Adhesion-induced chemoresistance in H69ad and N592ad was comparable to the resistance of NSCLC cell lines (IC 50 4.3 mg/ml for LCLC-103H with etoposide) but was significantly less than that in NCI-H69res (undergone long-term exposure to etoposide in vitro), in which the IC 50 was 35 mg/ml for etoposide. The degree of chemoresistance in H69ad and N592ad was greater than that of the SCLC cell lines NCI-H841 and NCI-H82 (IC 50 s for etoposide 1.5 mg/ml and 0.7 mg/ml respectively), which have been described by other groups as variant on the grounds of diminished neuroendocrine expression Gazdar and Minna, 1996) .
Increased resistance of adherent sublines to gamma radiation
The sensitivity of adherent SCLC sublines H69ad and N592ad to gamma radiation was found to be significantly lower than that of the parent cell lines. The response, measured by cytotoxicity assays, of N592ad and NCI-N592 at days 1, 2 and 3 after irradiation with 2 or 8 Gy compared to non-radiated controls, was dose-dependent with a maximal differential effect at day 3 ( Figure 5a ). Figure 5b illustrates the data at day 3 post-irradiation showing cell viability at 8 Gy of 83.6% for N592ad compared to 58.4% for NCI-N592 (P50.001) and 71.2% for H69ad compared to 58.9% for NCI-H69 (P50.001). To assess irradiation-induced apoptosis specifically, cultures were stained with the nuclear fluorescent dye Hoechst 33342, in which apoptotic nuclei were recognized morphologically by the pattern of fragmented DNA ( Figure 6 ). A dose-dependent response to irradiation was observed for NCI-H69 and its adherent subline, with a significant survival advantage in H69ad apparent at 8 Gy (Figure 7 ). NCI-N592 was more sensitive to gamma radiation than NCI-H69, displaying a significantly higher percentage of apoptotic nuclei at 2 Gy irradiation (12.3% in NCI-N592 compared to 4.3% in NCI-H69). The survival advantage of the adherent subline N592ad compared to its suspension parent cell line was marked at both 2 and 8 Gy ( Figure  7 ). The rate of apoptosis in cultures at day 3 after irradiation with 8 Gy was 4.5% for N592ad compared to 11.6% for NCI-N592 (P50.01) and 4.4% for H69ad compared to 7.8% for NCI-H69 (P50.05).
Constitutive activation of Akt and MAP kinase pathways in adherent sublines
Western analysis using phosphorylation-specific antibodies on protein from serum-starved cells demonstrated marked constitutive activation of the Axl is also strongly expressed in the suspension subclone H69.1 which was derived after transfection with Axl, but not in the suspension subclone H69.2 derived after transfection with fra-1. GAPDH serves as a control for c-DNA synthesis. The SCLC cell lines NCI-H24 and NCI-H841 and NSCLC cell lines NCI-H23 and EPLC-32M1 are used as controls Figure 8b ). Relatively low levels of active phosphorylated MAP kinase were present in NCI-H841 and the two NSCLC cell lines NCI-H23 and EPLC-32M1. The Akt signalling pathway in the adherent SCLC sublines was further investigated by examining the phosphorylation status of the Bad protein and NF-kB nuclear activity, which constitute two parallel arms of the downstream response to Akt phosphorylation. Activity of the MAP kinase-dependent nuclear transcription complex AP1 was also assessed. Figure 9 shows the results from immunoprecipitation experiments for Bad protein, demonstrating increased levels of Bad phosphorylation in the adherent sublines H69ad and N592ad relative to their parent cell lines. Similarly, the levels of active NF-kB and AP1 present in nuclear extracts were elevated in the adherent sublines relative to the parent cell lines as detected by electrophoretic mobility shift analysis (EMSA).
Inactive Akt in reverted adherent phenotype
Subculture of the established adherent sublines H69ad and N592ad in uncoated petri dishes (absence of poly-L-lysine coating) resulted in the cells failing to become adherent, and remaining as isolated suspension cells (H69rev and N592rev). Morphologically the cells reverted to the phenotype of the parent cell lines, proliferating in suspension as cell aggregates after 5 days of subculture. Western analysis of protein extracted from H69rev and N592rev within the first Figure 3 Graphical representation of differential RNA expression of gene products expressed as the difference in differential integrated density (DID) (y-axis) of expression in the adherent sublines H69ad and N592ad relative to their respective suspension parent cell lines. A negative difference in DID represents down-regulation in the adherent subline. GAPDH serves as control. An asterisk indicates that the analysis was not performed on N592ad and NCI-N592 for these gene products. Adherent sublines down-regulated expression of the neuroendocrine markers chromogranin A, L-dopa-decarboxylase, neuron-specific enolase (NSE), bombesin and c-kit relative to the parent cell lines. Expression of lung resistance protein and E cadherin was also downregulated in the adherent sublines. Conversely, expression of CD44, Axl, cyclin D1, thrombospondin and endothelin, as well as that of genes coding for the adhesion molecules integrin a2, a3 and b4 subunits, was up-regulated in the adherent sublines The relative resistance index indicates the degree of increased resistance in the adherent sublines to each chemotherapeutic agent 48 h of reverted phenotype is shown in Figure 10 . Here it can be seen that phosphorylated Akt is barely detectable in H69rev and N592rev, although levels are significant in the established adherent sublines, indicating that the activity of Akt is dependent on the adhesion status of the cells.
Discussion
Acquired resistance to chemo-and radio-therapy occurs commonly during treatment of small cell lung cancer (SCLC) and correlates with the appearance in the tumour of variant SCLC cells, exhibiting an epithelial 'adherent' phenotype. It has been shown that the growth and survival of SCLC cells is promoted by activation of the integrin family of cell adhesion molecules by extracellular matrix components (Sethi et al., 1999) . Adhesion via the integrins to fibronectin in myeloma cells (Hazlehurst et al., 2000) and to victronectin in glioma cells (Uhm et al., 1999) has been shown to mediate drug resistance. Such studies have led to the hypothesis that cell adhesion mediates resistance (cell adhesion-mediated drug resistance or CAM-DR), although it has not yet been established whether such a mechanism might account for the acquired resistance seen in SCLC. The identification and dissection of the intracellular pathways responsible for signal transduction from extracellular matrix stimuli in SCLC might provide attractive novel therapeutic targets. In order to achieve this, however, an appropriate cell culture model is required. We have previously reported that small cell lung cancer cells, which grow primarily as suspension aggregates, can be selected and subcultured under identical cell culture conditions for adherent growth, a phenomenon which occurs spontaneously and is associated with matrix metalloproteinase secretion Salge et al., 2001 ). An adherent SCLC cell model clearly offers the advantage of a homogeneous population of cancer cells, which can be analysed under rigorously defined experimental settings, differing only in the state of adherence. In this study we compared the gene expression and chemo-and radio-sensitivity of the adherent SCLC sublines, to establish whether they represent an in vitro model of variant differentiation in SCLC. This being the case, potential mechanisms of acquired resistance were investigated by comparison of protein kinase activity.
Differential gene expression analysis showed that expression of a variety of characteristic c-SCLC neuroendocrine markers , including chromogranin A, L-dopa-decarboxylase, NSE and bombesin were lost or diminished in the adherent sublines, while NSCLC markers such as CD44 (Wimmel et al., 1997) and cyclin D1 (Schauer et al., 1994) were up-regulated. Since this mirrors the pattern of expression seen in vivo in variant SCLC cells, spontaneously adherent SCLC sublines can be said to Figure 4 (a) and (b) Dose-dependent sensitivities of NCI-N592 and the adherent subline N592ad to each of etoposide, cyclophosphamide, doxorubicin and paclitaxel treatments. Cells were treated for 5 days before cytotoxicity assays were performed. N592ad was 71.7-fold more resistant than its parent cell line to etoposide, with IC 50 s of 16.5 and 0.23 mg/ml respectively. N592ad showed increased resistance to cyclophosphamide relative to NCI-N592, with IC 50 s of 560 mM and 99 mM respectively (5.6-fold increase). There were also modest differences in the responses of N592ad and NCI-N592 to doxorubicin and paclitaxel, with greater resistance in the adherent subline. Details of all respective IC 50 values are shown in Table 3 Figure 5 (a) Sensitivity to gamma radiation at 0, 2 and 8 Gy of the adherent SCLC subline N592ad compared to its parent suspension cell line NCI-N592, as measured by cytotoxicity assays at days 1, 2 and 3 after irradiation. The cell viability is proportional to the absorption. A dose-dependent response was observed, whereby N592ad was less sensitive to the effects of irradiation at both 2 and 8 Gy than its parent c-SCLC cell line. Maximal differential effect occurred at day 3. (b) Cell viability as a percentage of the untreated controls at day 3 after treatment with 0, 2 and 8 Gy. Asterisks indicate the levels of statistical significance in the differences for each set of responses (*P50.05, **P50.01, ***P50.001). The responses to 8 Gy irradiation demonstrated the most marked differences between parent c-SCLC and adherent sublines, with cell viability of 83.6% for N592ad versus 58.4% for NCI-N592 (P50.001) and 71.2% for H69ad versus 58.9% for NCI-H69 (P50.001) Figure 6 Fluorescence microscopy of NCI-H69 and adherent H69ad cells after irradiation with 0, 2 or 8 Gy and treated at day 3 post irradiation with the Hoechst dye 33342 to assess irradiation-induced apoptosis specifically. The arrow shows the typical characteristics of an apoptotic nucleus, with segmentation and systematic degradation of the fragmented DNA provide an in vitro model of variant differentiation in SCLC. The observed in vitro phenomenon of spontaneous adherent behaviour suggests that c-SCLC cells may differentiate spontaneously to v-SCLC in vivo.
Adherent SCLC cells were refractile to gamma irradiation, demonstrating a significantly reduced rate of apoptosis compared to the parent suspension cell lines. Our findings are consistent with a report by Brodin et al., 1995 of increased radio-resistance in the SCLC cell line U-1906 after long-term culture, when a more adherent growth pattern was spontaneously adopted. The sensitivity of our adherent SCLC sublines to etoposide and cyclophosphamide was also significantly diminished, with up to 70-fold increase in chemoresistance in comparison to the parent cell lines. These results give further evidence that the adherent sublines provide an in vitro model of variant SCLC and suggest that CAM-DR may play a role in the acquired resistance of variant SCLC cells. This is further supported by the finding that expression of certain integrin subunits, for example a2, a3 and b4, was up-regulated in the adherent sublines. The observed tolerance to chemo-and radio-therapy appears to be independent of classic multi-drug mechanisms (MDR1, MRP, LRP) and of cell cycleregulating kinases (p21 CIP or p27 KIP1 ), since expression of genes involved in either of these kinds of drug sensitivity modulation was not increased in the adherent sublines and LRP expression was actually down-regulated in H69ad.
Although certain SCLC cell lines have been described in the literature as 'variant' on the grounds of diminished neuroendocrine expression, their accuracy as a cell model is questionable since their sensitivity to radio-and chemo-therapy is comparable to that of the classic SCLC cell lines. For example, in our study the v-SCLC cell lines NCI-H82 and NCI-H841 demonstrated IC 50 s for etoposide equivalent to that of the c-SCLC cell line NCI-H69. In terms of radio-and chemo-therapy resistance the adherent SCLC sublines provide parallels to variant SCLC in vivo, which are not matched by other cell models to date.
Western analysis using phosphorylation-specific antibodies to Akt and MAP kinase revealed markedly elevated activation in adherent SCLC sublines, correlating with their increased chemo-and radio-resistance. Thus, activation of anti-apoptotic pathways dependent on Akt and MAP kinase activity appears to be central to acquired chemo-and radio-resistance in variant SCLC. Since, in the NSCLC cell lines investigated, activation of Akt was not detectable and MAP kinase was only minimally activated, the adherent SCLC sublines seem to constitute a separate entity from Figure 7 Rate of apoptosis (%) in the adherent SCLC sublines H69ad and N592ad and their respective parent cell lines at day 3 post gamma irradiation. Asterisks indicate the levels of statistical significance in the differences for each set of responses (*P50.05, **P50.01). A dose-dependent response to irradiation was observed for NCI-H69 and its adherent subline, with a significant survival advantage in H69ad apparent at 8 Gy. At both 2 and 8 Gy a statistically significant survival advantage was observed in the adherent subline N592ad over its parent cell line. NCI-N592 was generally more sensitive to gamma radiation than NCI-H69, although the responses of the two adherent sublines were comparable NSCLC, despite their similar morphology and expression of NSCLC markers.
The levels of phosphorylated Bad protein, an Akt substrate, and activated NF-kB were likewise increased in the adherent SCLC sublines. Akt is known to phosphorylate the Bcl-XL/Bcl-2-associated death promoter (Bad), promoting cell survival possibly by dissociating it from Bcl-XL and decreasing the amount of Bax homodimers (Datta et al., 1997) . As described in the introduction, NF-kB activity has also been shown recently to be dependent on Akt activity, with multiple downstream effects promoting survival (Ozes et al., 1999; Romashkova and Makarov, 1999) . Our results indicate that several parallel arms of the Akt response are responsible for the blockade of apoptosis in the adherent SCLC sublines, while concurrent activation of the MAP kinase pathway probably favours cell proliferation. NF-kB may influence the transcriptional activation of some of the marker genes shown to be present in the adherent sublines; for example, CD44 has a binding element in its promotor region for the transcription factors NF-kB and AP-1 (Risse-Hackl et al., 1998).
The adherent status of the SCLC sublines could be rapidly reverted by withdrawal of substrate when subcultured on uncoated petri dishes. The cells then reversed their adherent phenotype immediately to growth in suspension and under these conditions Akt activity reverted to low levels. This prompt reaction in Akt activity dependent on cellular adhesive properties, which we have observed bidirectionally in suspension and adherent states, is in keeping with the hypothesis of CAM-DR (Hazlehurst et al., 2000) . Our results suggest that cell -matrix interactions at the tumour -stroma interface generate cellular survival signals via their influence on Akt. Although the engagement of the integrin subunit b1 has been shown previously to play a role in CAM-DR (Sethi et al., 1999) , in our experimental system using RT -PCR we found no convincing differential expression of this molecule. Differential expression analysis in the adherent sublines indicated, however, that the integrin subunits a2, a3 and b4 are up-regulated, as are endothelin, thrombospondin, axl and CD 44, which all bear an influence on cellular adhesion. Further work is required to investigate whether integrins are exclusively responsible for the activation of the Akt pathway and which subunits are important in the case of SCLC.
The clinician's objective is to influence the acquired inhibition of apoptosis in SCLC by therapeutic measures. Our study suggests that this goal may be attainable by specifically inhibiting the activity of Akt. Although this is not yet feasible in the clinical setting, work is underway to develop effective antisense for Akt, at least for use under experimental conditions. Due to the short half-life of pharmacological inhibitors, blockade using wortmannin or LY 294002 to inhibit the PI 3-K/Akt pathway is problematic in our experimental system, where relatively low doses of irradiation were used to achieve exposure comparable to the clinical situation and assays lasted up to 5 days. In a recent study using high dose irradiation (50 Gy), wortmannin has been shown to have a radiosensitizing effect in A549 NSCLC cells, but SCLC cells were not investigated (Okada et al., 2001) . Recently the camptothecin analogue topotecan has been shown in A549 NSCLC cells, in addition to its effect as a topoisomerase I inhibitor, to promote Akt dephosphorylation, probably by directly inhibiting the upstream kinase PI-3 kinase (Nakashio et al., 2000) . This leads to down-regulation of the survival signalling pathway. Topotecan's potential effect on the Akt pathway in SCLC cells is of interest, especially given the promising clinical results with topotecan in treatment of relapsed SCLC patients (Grossi et al., 2001) .
In summary, SCLC cell cultures selected for adherent growth tend to de-differentiate, losing markers of neuronal differentiation and acquiring cellular characteristics typical of variant SCLC, together with activation of the Akt and MAP kinase pathways. Furthermore, adherent SCLC cells are refractile to gamma irradiation, with reduced rates of apoptosis, and show resistance to etoposide and cyclophosphamide. Our findings indicate that cellular adhesion triggers Akt-dependent inhibition of apoptosis in SCLC in vitro. This may account for the acquired chemo-and radio-resistance seen in patients with SCLC.
Materials and methods
Cell culture
The human lung carcinoma cell lines analysed included the small cell lung cancer (SCLC) lines NCI-N592, NCI-H69, NCI-H24, NCI-H841, NCI-H82 and, as non-small cell lung cancer (NSCLC) controls, the squamous cell carcinoma (SCC) line EPLC-32M1 and the adenocarcinoma (ADC) line NCI-H23. Cell line NCI-H69res was derived by long-term exposure to etoposide in vitro. All cell lines were cultured in RPMI 1640 (Gibco BRL, Eggenstein, Germany) supplemented with 10% heat-inactivated foetal calf serum (Gibco BRL, Eggenstein, Germany), 2 mM L-glutamine, penicillin (100 U/ Figure 10 Diminished Akt activity in reverted adherent SCLC sublines (H69rev and N592rev), which have undergone reversion from their established adherent epithelial morphology (H69ad and N592ad) to a suspension phenotype after withdrawal of their extracellular substrate, poly-L-lysine. Phosphorylated Akt is barely detectable in H69rev and N592rev, although levels are significant in the established adherent sublines, indicating that the activity of Akt is dependent on the adhesion status of the cells Figure 9 The Akt signalling pathway in the adherent SCLC sublines was investigated by examining the phosphorylation status of the Bad protein and NF-kB nuclear activity, which constitute two parallel arms of the downstream response to Akt phosphorylation. Immunoprecipitation for phosphorylated Bad protein shows increased levels of the phosphorylated protein in H69ad and N592ad relative to their respective parent cell lines, indicative of inhibited pro-apoptotic Bad activity in the adherent sublines. EMSA analysis shows increased activity of both NF-kB and AP1 in nuclear extracts from adherent SCLC sublines relative to the parent cell lines. This demonstrates that the NF-kB arm of the Akt signalling response has been activated by increased Akt activity in the adherent sublines and that the MAP kinase-dependent nuclear transcription complex AP1 has also been activated ml) and streptomycin (100 mg/ml), with three-times weekly three-quarter medium changes. Cells were cultivated at 378C in 5% CO 2 . Under these culture conditions, a small proportion of NCI-H69 and NCI-N592 suspension SCLC cells were noted to sink to the bottom of poly-L-lysine coated flasks, becoming spontaneously adherent and gaining an epithelial-type morphology over the course of several days. Once these adherent cells had proliferated sufficiently in the culture flask alongside their parental suspension cells to be viable on their own in culture, they were subcultured under identical culture conditions to create independent adherent H69ad and N592ad sublines, as also described elsewhere Salge et al., 2001) . The adherent sublines were susceptible to removal from the flask only after treatment with EDTA/trypsin solution, indicative of strong adherence. The NCI-H69.1 and NCI-H69.2 subclones (Axl and fra-1 transfected respectively) used have been previously described . Absence of cell contamination was confirmed by DNA fingerprint analysis of both the parent cell lines and adherent sublines using nine highly polymorphic STR markers (Thiede et al., 2001) to prove their identical genetic composition. The analysis was performed on an ABI Prism 377 Sequencer (Applied Biosystems, Weiterstadt, Germany) using GeneScan software.
RNA extraction and RT -PCR
Total RNA was extracted from all cell lines using RNAclean (Hybaid-AGS, Heidelberg, Germany) as described in the supplier's manual. cDNA synthesis was performed at 378C for 120 min in a volume of 30 ml containing 1 mg total RNA and Oligo(d)T as primer. RT -PCR was performed in a volume of 50 ml using 1 ml of the first-strand cDNA, 0.1 mg of each primer (forward and reverse), 1.25 mM of each dNTP, 16 PCR-buffer (Boehringer Mannheim, Germany), 1.5 mM MgCl 2 and one unit of Taq polymerase (Boehringer Mannheim, Germany) in the presence of a 33 P-dCTP. The primers shown in Table 4 were used at the given annealing temperatures. PCR conditions comprised denaturation at 948C for 1 min, annealing at specific temperature for 1 min and extension at 728C for 2 min for a variable number of cycles to attain maximal differential display. 10 ml aliquots of the reaction were electrophoresed on 6% polyacrylamide gels, which were then dried and exposed to X-ray films (X-Omat AR, Kodak, Stuttgart, Germany). Experiments were repeated at least twice to assess reproducibility. The differential integrated density of bands was determined using the software Gelscan 3D Professional (BioSciTec, Marburg, Germany).
Radiation treatment
Proliferating cells (10 5 /ml medium) in 96-or 6-well plates were g irradiated using a cobalt 60 Co source at a calibrated radiation dose rate of 1.4 Gy/min. Dosimetry was fully calibrated before commencing the experimental protocol. Standard cell conditions were maintained by performing a medium change 24 h before treatment and irradiating at a set time to avoid the effects of diurnal variation. Cells were irradiated with 2 or 8 Gy and assayed at 24, 48 and 72 h with appropriate controls. Experiments were repeated a minimum of three times.
Chemotherapy treatment
Proliferating cells (10 5 /ml medium) in 96-well plates were treated in replicates of eight to a titration dose of chemotherapeutic agent (etoposide, cyclophosphamide, placlitaxel, doxorubicin) ranging from 1 to 10 710 M with appropriate controls. Cells were incubated for a further 5 days before assaying. Experiments were repeated a minimum of three times.
Cytotoxicity assay
Cells from the chemotherapy and radiation experiments performed in 96-well plates were tested in replicates of eight with a commercially available kit to assess the number of metabolically active cells present, according to the suppliers' instructions (Cell Titer 96 One Solution Assay, Promega, Mannheim, Germany). Each well was incubated for 4 h with 20 ml of a tetrazolium-containing dye solution at 378C in a humidified 5% CO 2 atmosphere. The absorbence was read at 490 nm wavelength using an ELISA plate reader. The mean percentage reduction in absorbence between the control and treated samples, each of which had been in culture for identical time periods, was taken to represent the percentage cell response (accounted for by cell death and/or slowed proliferation) within the irradiated samples.
Detection of apoptosis
Irradiated cells were harvested at 72 h, centrifuged, resuspended in 100 ml Hoechst dye 33342 (at 10 mmol/l effective dye solution) and incubated for 20 min in the dark at room temperature. The cells were then subjected to fluorescence microscopy and assessed for the presence of morphological features of apoptosis. A minimum of five visual fields was counted per slide.
Statistical analysis
Statistical analysis (Student's t-test) was performed using standard software.
